Is there a generic for Aspirin; methocarbamol?

Yes. The FDA Orange Book lists 4 approved generic (ANDA) applications for Aspirin; methocarbamol, referencing the brand ROBAXISAL. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Aspirin; methocarbamol?

ROBAXISAL (NDA 012281, ROBINS AH) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Aspirin; methocarbamol are approved?

Aspirin; methocarbamol is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Aspirin; methocarbamol

Aspirin; methocarbamol is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ROBAXISAL · NDA 012281

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
ROBAXISALRLD	ROBINS AH	NDA 012281	—	Approved Prior to Jan 1, 1982

Generic (ANDA) products (4)

Product	Applicant	Application	TE	Approved
METHOCARBAMOL AND ASPIRIN	STEVENS J	ANDA 081145	—	Jan 31, 1995
METHOCARBAMOL AND ASPIRIN	PAR PHARM	ANDA 089657	—	Nov 04, 1988
METHOCARBAMOL AND ASPIRIN	MCNEIL	ANDA 089193	—	Feb 12, 1986
METHOCARBAMOL AND ASPIRIN	IVAX SUB TEVA PHARMS	ANDA 087211	—	Dec 22, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aspirin; methocarbamol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo